Proteome Sciences Pl (PMSNF) 0.2050 $PMSNF
33-Country Molecular Diagnostics Market Report - Analysis, Technologies, Opportunities & Forecast 2016-2021 - Key Vendors: Abbott, Arca Biopharma
M2 - Fri Feb 05, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/krshdj/a_33country) has announced the addition of the "A 33-Country Survey of the Molecular Diagnostics Market" report to their offering. This new 33-country survey contains over 1,600 pages, 350 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Supplier sales and market shares in major countries - Five-year test volume and sales forecasts - Strategic profiles of market players and start-up firms developing innovative technologies and products - Emerging technologies - Review of molecular diagnostic analyzers - Specific product and business opportunities for instrument and consumable suppliers The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kr..._33country
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
39 Country Blood Typing, Grouping & Infectious Disease Screening Market Survey - Analysis, Technologies & Forecasts 2016 - Key Vendors: Abbott, Becton Dickinson & Bio-Rad
M2 - Thu Feb 04, 10:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/69t293/a_39country) has announced the addition of the "A 39-Country Survey of the Blood Typing, Grouping and Infectious Disease Screening Market" report to their offering. This comprehensive 39-country report contains 1,025 pages, 387 tables and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. Blood Group Genotyping: - PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays: - BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests: - ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests: - AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT. Countries Analyzed: - Armenia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, - Japan, Latvia, Luxembourg, Malta, Moldova, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, UK, US Contains 1,025 pages and 387 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/69..._39country
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Canada Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/psx4dl/2016_canada) has announced the addition of the "2016 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/ps...016_canada
SQNM: 0.85 (-0.05), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Ireland Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6zczz/2016_ireland) has announced the addition of the "2016 Ireland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/k6...16_ireland
A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Wed Feb 03, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/w25rjt/2016_u_s) has announced the addition of the "2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Grifols - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/w25rjt/2016_u_s
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11)
2016 U.S. Transfusion Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities
M2 - Wed Feb 03, 3:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/m9v5jx/2016_u_s) has announced the addition of the "2016 U.S. Transfusion Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities" report to their offering. This new report is a strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/m9v5jx/2016_u_s
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
2016 U.S. Nucleic Acid Testing/NAT Market - Sales and Market Shares of Major Suppliers
M2 - Tue Feb 02, 10:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t27jjr/2016_u_s_nucleic) has announced the addition of the "2016 U.S. Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/t2..._s_nucleic
MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11)
2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
M2 - Tue Feb 02, 10:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/3m8nhx/2016_u_s_genetic) has announced the addition of the "2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others Product/Technology Review - Comparison of the major molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostict echnologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Illumina - Kreatech/Leica - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/3m..._s_genetic
LIFE: 2.80 (-0.14), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11)
2016 Global Blood Banking Market Report - Analysis, Technologies, Opportunities & Forecasts
M2 - Tue Jan 12, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/qdqlp8/competing_in_the) has announced the addition of the "Competing in the 2016 Global Blood Banking Market" report to their offering. This new 775-page seven-countrystudy is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. During the next five years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis: - Sales and market share estimates for leading suppliers of transfusion diagnostic testing reagents and instruments, by country and individual product. Instrument Placements: - Annual placements and installed base of major automated and semi-automated analyzers, by supplier and model. - Competitive Assessments: - Strategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 transfusion diagnostic tests, including NAT, by country and market segment: Blood Centers, Plasma Fractionation Facilities, Hospitals, Commercial/Private Laboratories, Military Blood Banks Contains 775 pages and 227 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/qd...ing_in_the
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Transfusion Diagnostic Assays Analysis Report 2016-2019 (Abbott, Bio-Rad, Roche & More)
M2 - Mon Jan 04, 2:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/3zzm6h/20152019) has announced the addition of the "2015-2019 Analysis of Transfusion Diagnostic Assays, and Strategic Profiles of Leading Suppliers" report to their offering. This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 280 pages and 6 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher Report Structure: 1. Blood Typing and Grouping Tests 2. Blood Group Genotyping 3. Infectious Disease Screening Tests 4. Pathogen Reduction 5. Leukocyte Reduction List of Tables: Blood Typing and Grouping Tests HLA Typing Tests AIDS Tests Hepatitis Tests CMV Tests Syphilis Tests For more information visit http://www.researchandmarkets.com/research/3zzm6h/20152019
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
European Molecular Blood Typing, Grouping and Infectious Disease NAT Market Report - Analysis & Forecasts 2016
M2 - Tue Dec 29, 11:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/czj548/2016_european) has announced the addition of the "2016 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Market Segmentation Analysis: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment. Current and Emerging Products: - Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. - Review of automated and semi-automated molecular and immunohematology analyzers. Technology Review: - Assessment of current and emerging technologies, and their potential applications for the blood banking market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. Strategic Recommendations: - New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 630 pages and 152 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/cz...6_european
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Nucleic Acid Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Tue Dec 29, 10:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/2gjbfn/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This unique seven-country report contains 1,398-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Contains 1398 pages and 194 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/2g...016_future
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Future Horizons & Growth Strategies in the UK Molecular Diagnostics Market: Shares, Forecasts, Intelligence & Opportunities 2016
M2 - Tue Dec 29, 10:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/kmpt6j/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the UK Molecular Diagnostics Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This new 1122-page report contains 53 tables, and presents a comprehensive analysis of the UK molecular diagnostics market, including:Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.Ten-year test volume and reagent sales forecasts for the following categories: - Infectious Diseases - Genetic Diseases - Cancer - Paternity Testing/HLA Typing - Forensic Testing Review of testing methodologies an instrumentation technologies.Feature comparison of automated and semiautomated analyzers.Sales and market shares of leading suppliers.Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Alternative market penetration strategies.Potential market entry barriers and risks.Business planning issues and concerns.Contains 1,122 pages and 53 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/km...016_future
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Molecular Diagnostic Product Suppliers Report 2016 - Sales & Market Shares by Test and Country
M2 - Tue Dec 29, 9:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/7g8r2r/2016_global) has announced the addition of the "2016 Global Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test and Country" report to their offering. This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/7g...016_global
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Transfusion Diagnostic Testing Market Report - Analysis, Technologies, Trends & Forecast 2016
M2 - Wed Dec 23, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/8bq9wd/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Transfusion Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment. - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. - Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. - Estimates of facilities performing transfusion diagnostic tests, by country. - Test volume and sales projections by country. - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 775 pages and 227 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/8b...016_future
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
European Transfusion Diagnostic Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Wed Dec 23, 9:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/zh3x3d/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the European Transfusion Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the Europe; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment. - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. - Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 600 pages and 170 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/zh...016_future
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
UK Transfusion Diagnostic Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Wed Dec 23, 9:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/w7vh9w/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the UK Transfusion Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: - Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. - Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. - Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 422 pages and 39 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/w7...016_future
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
European Nucleic Acid Testing/NAT Market: Analysis, Opportunities, Technologies & Expansion Strategies 2016
M2 - Wed Dec 23, 8:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/3ctd67/2016_european) has announced the addition of the "2016 European Nucleic Acid Testing/NAT Market: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Contains 1,273 pages and 139 tables. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/3c...6_european
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Emerging Transfusion Diagnostic Technologies & Strategic Profiles of Leading Suppliers 2016
M2 - Tue Dec 22, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/ss4xg2/2016_emerging) has announced the addition of the "2016 Emerging Transfusion Diagnostic Technologies and Strategic Profiles of Leading Suppliers" report to their offering. This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 114 pages Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/ss...6_emerging
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Blood Bank Instrumentation Review: Testing Analyzers & Strategic Profiles of Leading Suppliers 2015
M2 - Tue Dec 22, 8:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/qdbncv/2015_blood_bank) has announced the addition of the "2015 Blood Bank Instrumentation Review: Transfusion Diagnostic Testing Analyzers and Strategic Profiles of Leading Suppliers" report to their offering. This 68-page report reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 68 pages Companies Mentioned Include: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/qd...blood_bank
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
33-Country Molecular Diagnostics Market Report - Analysis, Technologies, Opportunities & Forecast 2016-2021 - Key Vendors: Abbott, Arca Biopharma
M2 - Fri Feb 05, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/krshdj/a_33country) has announced the addition of the "A 33-Country Survey of the Molecular Diagnostics Market" report to their offering. This new 33-country survey contains over 1,600 pages, 350 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Supplier sales and market shares in major countries - Five-year test volume and sales forecasts - Strategic profiles of market players and start-up firms developing innovative technologies and products - Emerging technologies - Review of molecular diagnostic analyzers - Specific product and business opportunities for instrument and consumable suppliers The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kr..._33country
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
39 Country Blood Typing, Grouping & Infectious Disease Screening Market Survey - Analysis, Technologies & Forecasts 2016 - Key Vendors: Abbott, Becton Dickinson & Bio-Rad
M2 - Thu Feb 04, 10:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/69t293/a_39country) has announced the addition of the "A 39-Country Survey of the Blood Typing, Grouping and Infectious Disease Screening Market" report to their offering. This comprehensive 39-country report contains 1,025 pages, 387 tables and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. Blood Group Genotyping: - PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays: - BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests: - ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests: - AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT. Countries Analyzed: - Armenia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, - Japan, Latvia, Luxembourg, Malta, Moldova, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, UK, US Contains 1,025 pages and 387 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/69..._39country
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Canada Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/psx4dl/2016_canada) has announced the addition of the "2016 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/ps...016_canada
SQNM: 0.85 (-0.05), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Ireland Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6zczz/2016_ireland) has announced the addition of the "2016 Ireland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/k6...16_ireland
A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Wed Feb 03, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/w25rjt/2016_u_s) has announced the addition of the "2016 U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Grifols - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/w25rjt/2016_u_s
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11)
2016 U.S. Transfusion Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities
M2 - Wed Feb 03, 3:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/m9v5jx/2016_u_s) has announced the addition of the "2016 U.S. Transfusion Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities" report to their offering. This new report is a strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/m9v5jx/2016_u_s
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
2016 U.S. Nucleic Acid Testing/NAT Market - Sales and Market Shares of Major Suppliers
M2 - Tue Feb 02, 10:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t27jjr/2016_u_s_nucleic) has announced the addition of the "2016 U.S. Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/t2..._s_nucleic
MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11)
2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
M2 - Tue Feb 02, 10:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/3m8nhx/2016_u_s_genetic) has announced the addition of the "2016 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others Product/Technology Review - Comparison of the major molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostict echnologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Illumina - Kreatech/Leica - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/3m..._s_genetic
LIFE: 2.80 (-0.14), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11)
2016 Global Blood Banking Market Report - Analysis, Technologies, Opportunities & Forecasts
M2 - Tue Jan 12, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/qdqlp8/competing_in_the) has announced the addition of the "Competing in the 2016 Global Blood Banking Market" report to their offering. This new 775-page seven-countrystudy is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. During the next five years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Sales and Market Share Analysis: - Sales and market share estimates for leading suppliers of transfusion diagnostic testing reagents and instruments, by country and individual product. Instrument Placements: - Annual placements and installed base of major automated and semi-automated analyzers, by supplier and model. - Competitive Assessments: - Strategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 transfusion diagnostic tests, including NAT, by country and market segment: Blood Centers, Plasma Fractionation Facilities, Hospitals, Commercial/Private Laboratories, Military Blood Banks Contains 775 pages and 227 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/qd...ing_in_the
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Transfusion Diagnostic Assays Analysis Report 2016-2019 (Abbott, Bio-Rad, Roche & More)
M2 - Mon Jan 04, 2:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/3zzm6h/20152019) has announced the addition of the "2015-2019 Analysis of Transfusion Diagnostic Assays, and Strategic Profiles of Leading Suppliers" report to their offering. This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 280 pages and 6 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher Report Structure: 1. Blood Typing and Grouping Tests 2. Blood Group Genotyping 3. Infectious Disease Screening Tests 4. Pathogen Reduction 5. Leukocyte Reduction List of Tables: Blood Typing and Grouping Tests HLA Typing Tests AIDS Tests Hepatitis Tests CMV Tests Syphilis Tests For more information visit http://www.researchandmarkets.com/research/3zzm6h/20152019
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
European Molecular Blood Typing, Grouping and Infectious Disease NAT Market Report - Analysis & Forecasts 2016
M2 - Tue Dec 29, 11:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/czj548/2016_european) has announced the addition of the "2016 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Market Segmentation Analysis: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment. Current and Emerging Products: - Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. - Review of automated and semi-automated molecular and immunohematology analyzers. Technology Review: - Assessment of current and emerging technologies, and their potential applications for the blood banking market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. Strategic Recommendations: - New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 630 pages and 152 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/cz...6_european
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Nucleic Acid Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Tue Dec 29, 10:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/2gjbfn/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This unique seven-country report contains 1,398-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Contains 1398 pages and 194 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/2g...016_future
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Future Horizons & Growth Strategies in the UK Molecular Diagnostics Market: Shares, Forecasts, Intelligence & Opportunities 2016
M2 - Tue Dec 29, 10:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/kmpt6j/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the UK Molecular Diagnostics Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This new 1122-page report contains 53 tables, and presents a comprehensive analysis of the UK molecular diagnostics market, including:Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.Ten-year test volume and reagent sales forecasts for the following categories: - Infectious Diseases - Genetic Diseases - Cancer - Paternity Testing/HLA Typing - Forensic Testing Review of testing methodologies an instrumentation technologies.Feature comparison of automated and semiautomated analyzers.Sales and market shares of leading suppliers.Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Alternative market penetration strategies.Potential market entry barriers and risks.Business planning issues and concerns.Contains 1,122 pages and 53 tables Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/km...016_future
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Molecular Diagnostic Product Suppliers Report 2016 - Sales & Market Shares by Test and Country
M2 - Tue Dec 29, 9:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/7g8r2r/2016_global) has announced the addition of the "2016 Global Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test and Country" report to their offering. This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/7g...016_global
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Global Transfusion Diagnostic Testing Market Report - Analysis, Technologies, Trends & Forecast 2016
M2 - Wed Dec 23, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/8bq9wd/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Transfusion Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment. - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. - Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. - Estimates of facilities performing transfusion diagnostic tests, by country. - Test volume and sales projections by country. - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 775 pages and 227 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/8b...016_future
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
European Transfusion Diagnostic Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Wed Dec 23, 9:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/zh3x3d/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the European Transfusion Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in the Europe; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment. - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. - Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 600 pages and 170 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/zh...016_future
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
UK Transfusion Diagnostic Testing Market Report - Analysis, Technologies, Trends & Forecasts 2016
M2 - Wed Dec 23, 9:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/w7vh9w/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the UK Transfusion Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: - Sales and market share estimates for leading suppliers of transfusion diagnostic products by individual product. - Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D. - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. - Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Contains 422 pages and 39 tables Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/w7...016_future
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
European Nucleic Acid Testing/NAT Market: Analysis, Opportunities, Technologies & Expansion Strategies 2016
M2 - Wed Dec 23, 8:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/3ctd67/2016_european) has announced the addition of the "2016 European Nucleic Acid Testing/NAT Market: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Contains 1,273 pages and 139 tables. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/3c...6_european
SQNM: 0.85 (-0.05), MYGN: 30.59 (-0.18), A: 43.66 (-0.94), CPHD: 31.95 (-1.24), DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Emerging Transfusion Diagnostic Technologies & Strategic Profiles of Leading Suppliers 2016
M2 - Tue Dec 22, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/ss4xg2/2016_emerging) has announced the addition of the "2016 Emerging Transfusion Diagnostic Technologies and Strategic Profiles of Leading Suppliers" report to their offering. This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 114 pages Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/ss...6_emerging
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
Blood Bank Instrumentation Review: Testing Analyzers & Strategic Profiles of Leading Suppliers 2015
M2 - Tue Dec 22, 8:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/qdbncv/2015_blood_bank) has announced the addition of the "2015 Blood Bank Instrumentation Review: Transfusion Diagnostic Testing Analyzers and Strategic Profiles of Leading Suppliers" report to their offering. This 68-page report reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 68 pages Companies Mentioned Include: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/qd...blood_bank
DHR: 79.21 (-23.11), HOLX: 34.28 (-0.57)
